254 related articles for article (PubMed ID: 18821703)
1. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
Schett G; Stach C; Zwerina J; Voll R; Manger B
Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
[No Abstract] [Full Text] [Related]
2. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
Redlich K; Schett G; Steiner G; Hayer S; Wagner EF; Smolen JS
Arthritis Rheum; 2003 Dec; 48(12):3308-19. PubMed ID: 14673982
[No Abstract] [Full Text] [Related]
3. Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
Quinn M
J Rheumatol; 2008 Mar; 35(3):372-4. PubMed ID: 18322971
[No Abstract] [Full Text] [Related]
4. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
Goldring SR
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
[TBL] [Abstract][Full Text] [Related]
5. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.
Weitoft T; Larsson A; Saxne T; Rönnblom L
Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449
[TBL] [Abstract][Full Text] [Related]
6. [Redefining treatment of rheumatic arthritis with anti-cytokines].
Gabay C; So A
Rev Med Suisse; 2007 Mar; 3(103):715-7. PubMed ID: 17458148
[No Abstract] [Full Text] [Related]
7. Bone effects of biologic drugs in rheumatoid arthritis.
Corrado A; Neve A; Maruotti N; Cantatore FP
Clin Dev Immunol; 2013; 2013():945945. PubMed ID: 23864880
[TBL] [Abstract][Full Text] [Related]
8. Bone loss in rheumatoid arthritis: what role does inflammation play?
Lane NE; Goldring SR
J Rheumatol; 1998 Jul; 25(7):1251-3. PubMed ID: 9676751
[No Abstract] [Full Text] [Related]
9. Increased adiponectin levels in women with rheumatoid arthritis after etanercept treatment.
Lewicki M; Kotyla P; Kucharz E
J Rheumatol; 2009 Jun; 36(6):1346-7; author reply 1347. PubMed ID: 19509093
[No Abstract] [Full Text] [Related]
10. Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis.
Makrygiannakis D; Catrina AI
J Rheumatol; 2012 Apr; 39(4):679-85. PubMed ID: 22422498
[TBL] [Abstract][Full Text] [Related]
11. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality?
van den Berg WB; van Riel PL
Arthritis Rheum; 2005 Apr; 52(4):995-9. PubMed ID: 15818666
[No Abstract] [Full Text] [Related]
13. Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis.
Alcorn N; Tierney A; Wu O; Gilmour H; Madhok R
Ann Rheum Dis; 2010 Aug; 69(8):1571. PubMed ID: 20388741
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis: time for trials of therapeutic targets.
Edmonds J; Lassere M
J Rheumatol; 2002 Oct; 29(10):2041-4. PubMed ID: 12375309
[No Abstract] [Full Text] [Related]
15. [Cellular and enzyme mechanisms of bone and cartilage resorption].
Vaes G
Bull Mem Acad R Med Belg; 1983; 138(3):196-204. PubMed ID: 6317107
[No Abstract] [Full Text] [Related]
16. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
[No Abstract] [Full Text] [Related]
17. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
Williams RO; Feldmann M; Maini RN
Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i75-80. PubMed ID: 11053094
[No Abstract] [Full Text] [Related]
18. [Treatment of rheumatoid arthritis with cytokine antagonists].
Manger B
Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):101-4. PubMed ID: 10355058
[TBL] [Abstract][Full Text] [Related]
19. [Current aspects of the immunology of articular cartilage].
Miossec P; Sany J
Rev Rhum Mal Osteoartic; 1987; 54(7-9):595-600. PubMed ID: 3313671
[No Abstract] [Full Text] [Related]
20. Matrix catabolism in arthritis: priming the guns with oncostatin M.
Richards CD
J Rheumatol; 2004 Dec; 31(12):2326-8. PubMed ID: 15570629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
